GlassScriptPhysician profile
Gregory Arkady Avetisov
NPI 1679917280
$801.08
in general payments reported to CMS, 2019-2025
18 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $74.10 · 2021: $68.57 · 2022: $122 · 2023: $15.93 · 2024: $288 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $172.32 | 2020-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $121.82 | 2022 | |
| Abbvie INC. | $97.19 | 2021-2025 | Vraylar |
| Lilly USA, LLC | $79.80 | 2024-2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $72.05 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Xeris Pharmaceuticals, INC. | $38.91 | 2024 | Gvoke Hypopen |
| Amarin Pharma, INC. | $33.19 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.75 | 2024 | |
| Novartis Pharmaceuticals Corporation | $20.70 | 2021 | |
| Gilead Sciences, INC. | $19.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.24 | 2024 | Spravato |
| Scilex Pharmaceuticals INC. | $17.71 | 2024 | |
| Mannkind Corporation | $15.10 | 2025 | |
| Abiomed | $14.34 | 2024 | Impella |
| Idorsia Pharmaceuticals US INC | $14.21 | 2024 | Quviviq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $13.47 | 2025 | Immunocap |
| Kowa Pharmaceuticals America, INC. | $12.95 | 2020 | |
| Amgen INC. | $12.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Avetisov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.